NovoCure (NVCR) SEC Filings & 10K Form

$12.30
-0.04 (-0.32%)
(As of 03:10 PM ET)

Recent NovoCure SEC Filings

DateFilerForm TypeView
03/27/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:39 PM
NovoCure (Subject)
Shah Pritesh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
5:17 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:43 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:35 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
6:11 AM
NovoCure (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
6:05 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
6:06 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:28 AM
FMR LLC (Filed by)
NovoCure (Subject)
Form SC 13G/A
01/18/2024
6:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2024
3:57 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2024
4:15 PM
Leupin Nicolas (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/09/2024
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:10 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:10 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:23 PM
Giladi Moshe (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2023
5:19 AM
Capital World Investors (Filed by)
NovoCure (Subject)
Form SC 13G/A
11/28/2023
6:30 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
5:15 AM
BAILLIE GIFFORD & CO (Filed by)
NovoCure (Subject)
Form SC 13G/A
11/08/2023
3:22 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
4:15 PM
NovoCure (Issuer)
Puri Michal Nath (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/02/2023
3:20 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/26/2023
6:03 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
3:23 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:24 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:24 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:40 PM
Cordova Ashley (Reporting)
NovoCure (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
6:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/27/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/27/2023
6:03 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
7:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2023
3:12 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:13 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:13 PM
Ben Arye Barak (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
Burke William Patrick (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:14 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…
06/06/2023
2:45 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
11:18 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
7:00 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
3:34 PM
NovoCure (Issuer)
Stafford Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
6:02 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
6:02 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2023
6:06 AM
NovoCure (Filer)
Form DEF 14A
04/24/2023
6:08 AM
NovoCure (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NVCR) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners